Li Zhang

机构：Qingdao Agricultural University, Sun Yat-sen University, Wenzhou Medical University, Tianjin Medical University Cancer Institute and Hospital, Guangzhou Women and Children Medical Center, Jinan Central Hospital, Nanchang Normal University, Sun Yat-sen University Cancer Center, Dongyang People's Hospital, Shandong First Medical University, State Key Laboratory of Oncology in South China, Guangzhou Medical University · ORCID：0000-0001-7847-2452

发表论文 59 篇 · 总被引 764 次 · h-index 12

代表论文

• Baicalin suppresses macrophage JNK-mediated adipose tissue inflammation to mitigate insulin resistance in obesity (2024 · Journal of Ethnopharmacology · 被引 25)
• Ivonescimab combined with chemotherapy in patients with EGFR-mutant non-squamous non-small cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor treatment (HARMONi-A): A randomized, double-blind, multi-center, phase 3 trial. (2024 · Journal of Clinical Oncology · 被引 14)
• Gut microbiota alterations in postmenopausal women with osteoporosis and osteopenia from Shanghai, China (2024 · PeerJ · 被引 13)
• Alectinib Versus Crizotinib in Asian Patients With Treatment-Naïve Advanced ALK-Positive NSCLC: Five-Year Update From the Phase 3 ALESIA Study (2024 · JTO Clinical and Research Reports · 被引 12)
• Chidamide plus envafolimab as subsequent treatment in advanced non‐small cell lung cancer patients resistant to anti‐PD‐1 therapy: A multicohort, open‐label, phase II trial with biomarker analysis (2024 · Cancer Medicine · 被引 8)
• Combined analysis of metabolomic, transcriptomic and proteomics to reveal the underlying mechanism of mucilage disappearance in Brasenia schreberi (2025 · Industrial Crops and Products · 被引 6)